Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
Clinical trial NCT01295112 · COMPLETED
Trial details
- NCT number
- NCT01295112
- Sponsor
- Texas Retina Associates
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2015-10-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.